2020
Drug use associated tricuspid valve infective endocarditis in pregnancy
Lin D, Mullan CW, Deshmukh U, Bahtiyar MO, Hosier H, Lipkind H, Abdel‐Razeq S, Ranjan S, Lancaster G, Pietras C. Drug use associated tricuspid valve infective endocarditis in pregnancy. Journal Of Cardiac Surgery 2020, 35: 2392-2395. PMID: 32720414, DOI: 10.1111/jocs.14888.Peer-Reviewed Original ResearchConceptsDrug useTricuspid valve infective endocarditisWeeks 6 days' gestationAppropriate intravenous antibioticsTricuspid valve endocarditisLife-threatening complicationsIntravenous drug useNeonatal critical careIntravenous antibioticsCesarean deliveryPerioperative periodValve endocarditisCardiac surgeryInfective endocarditisCritical careDays gestationPatient managementPregnant femalesEndocarditisMultidisciplinary collaborationPatientsGestationComplicationsPregnancySurgery
2019
Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center
Grechukhina O, Deshmukh U, Fan L, Kohari K, Abdel-Razeq S, Bahtiyar M, Sfakianaki A. Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center. Obstetric Anesthesia Digest 2019, 39: 98-99. DOI: 10.1097/01.aoa.0000557687.83837.90.Peer-Reviewed Original ResearchCesarean scar pregnancyScar pregnancyTreatment modalitiesSingle tertiary care referral centerTertiary care referral centerYale-New Haven HospitalLife-threatening complicationsNumerous treatment modalitiesTertiary care centerOptimal treatment modalityFive-year experiencePrevious hysterotomySac implantsPregnancy outcomesReferral centerPatient counselingCare centerTreatment decisionsPregnancyAvailable literaturePresent studyModalitiesHysterotomyComplicationsRecurrence